The largest database of trusted experimental protocols

Accell non targeting sirna pool

Manufactured by Horizon Discovery
Sourced in United States

The Accell Non-targeting siRNA Pool is a reagent designed for use as a control in RNA interference (RNAi) experiments. It consists of a pool of siRNA sequences that do not target any known gene in the human, mouse, or rat genome. This pool can be used to assess the non-specific effects of siRNA delivery and to establish baseline cellular responses in RNAi studies.

Automatically generated - may contain errors

8 protocols using accell non targeting sirna pool

1

Targeted Gene Knockdown in Corneal Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For gene knockdown by siRNA, Accell SMARTpool system was used as previously reported.28 (link) Corneal endothelial cells at 70% confluence or ex vivo corneal endothelium were transfected on six-well plate with 1.5 µmol/L Accell SMARTpool of siRNA targeting ZEB1, SP1 or SP3 (Dharmacon, Pittsburgh, PA, USA) in Accell delivery medium according to the manufacturer's instructions. Seventy-two hours after transfection, the medium was changed to medium containing FGF2. Ten days after maintaining, another transfection with 1.5 µmol/L Accell SMARTpool of siRNA targeting ZEB1, SP1 or SP3 were performed and maintained four more days with FGF2. RNA and protein levels of ZEB1, SP1, or SP3 were analyzed by RT-PCR and immunoblotting, respectively. Accell non-targeting pool siRNA (Dharmacon) was used as a negative control, and transfection efficiency was confirmed with Accell Red Cyclophilin B Control siRNA (Dharmacon).
+ Open protocol
+ Expand
2

siRNA and Overexpression Experiments in SHSY5Y Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For siRNA studies, day 10 differentiated SHSY5Y cells had their media replaced with Accell siRNA Delivery Media (Dharmacon #B-005000-500) supplemented with 50 ng/ml BDNF (Peprotech #450-02B). Either Accell Non-targeting Pool siRNA (Dharmacon #D-001910-10-20) or Accell Human pooled LGMN siRNA (Dharmacon #E-005924-00-0010) was added to the cells at a concentration of 2uM. After 72 h, the media was replaced with EMEM/F12 with 50 ng/mL BDNF. Cells were collected after 96 h and collected for western blot analysis. For overexpression studies, pCMV6 mammalian expressing vectors carrying the cDNA of AEP and CTSL were ordered from Origene (#RC224975 and #RC203143). XtremeGene HP (Sigma, #06366236001) was used to transiently transfect HEK293FT cells for 24 h following the manufacturers suggestions. The cells were then pelleted and prepared for western blotting as described below.
+ Open protocol
+ Expand
3

Knockdown of APOBEC3A and ISG20 in dHepaRG cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
dHepaRG cells were transfected overnight with 0.75 µl DharmaFECT 1 siRNA Transfection Reagent (GE Healthcare Dharmacon, Lafayette, CO, USA) per well of a 12‐well plate according to the manufacturer’s instructions. 20 nM Accell human APOBEC3A (200315) siRNA SMARTpool (#E‐017432‐00‐0005, GE Healthcare Dharmacon), 20 nM Accell human ISG20 siRNA SMARTpool (#E‐015994‐00‐0005, GE Healthcare Dharmacon), or 20 nM Accell non‐targeting pool siRNA (#D‐001910‐10‐05, GE Healthcare Dharmacon) was applied. Alternatively, synthetic oligonucleotides (sequences adapted from The RNAi Consortium Collection, Mission shRNA, Sigma‐Aldrich; listed in Appendix Table S1) were annealed and ligated into a HindIII‐ and SalI‐digested pEntry backbone with H1 promoter to generate adenoviral vectors following the Gateway approach (pAd/PL‐DEST Gateway Vectors and Virapower Adenoviral Expression Systems, Invitrogen, Carlsbad, CA, USA). Resulting constructs were transfected in HEK293 cells to amplify the adenoviral vector AdV‐shISG20, and infectious units (i.u.) were determined in HEK293 cells. dHepaRG cells were transduced using an MOI of 3 i.u./cell in DMEM without supplements for 2 h.
+ Open protocol
+ Expand
4

Rab5a Silencing in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Accell Mouse Rab5a siRNA SMART pool and Accell Non-targeting siRNA Pool were purchased from Dharmacon (Lafayette, USA). Transfections were performed according to the manufacturer’s instructions and silencing efficiency was verified by immunoblotting.
+ Open protocol
+ Expand
5

Regulating Corneal Endothelial FGF2 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Accell SMARTpool system (Dharmacon, Pittsburgh, PA) was used for siRNA knockdown as previously reported [36 (link),39 (link)]. The mouse corneal endothelium was transfected on a 96-well plate with 1.5 μM Accell SMARTpool of siRNA targeting FGF2 in Accell delivery medium according to the manufacturer’s instructions. Seventy-two hours after transfection, based on our experience with human ex vivo CEs [36 (link)], the medium was changed to medium containing IL-1β. Ten days after the addition of IL-1β, another transfection with 1.5 μM Accell SMARTpool of siRNA targeting FGF2 was performed, and the corneas were cultured for 4 additional days in the presence of IL-1β. The efficacy of FGF2 siRNA was verified with FGF2 RT–PCR. The Accell non-targeting siRNA pool (Dharmacon) was used as a negative control, and transfection efficiency was confirmed with Accell Red Cyclophilin B Control siRNA (Dharmacon).
+ Open protocol
+ Expand
6

Targeting Phb2 in Th17 Polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pre-designed SMARTpool Accell Mouse Phb2 siRNA (#E-040938-00-0020, product of GE Healthcare Dharmacon Inc., Lafayette, CO; purchased from Thermo Scientific) was used to target Rea (also named prohibitin 2, Phb2). Accell Non-targeting siRNA Pool(#D-001910-10-20, product of GE Healthcare Dharmacon Inc., Lafayette, CO; purchased from Thermo Scientific; contained four siRNAs that were designed with no homology to known human, mouse, or rat genes)was used as negative control. One μmol/L targeting or non-targeting siRNAs were added to naïve T cells for 3-day incubation using Accell siRNA Delivery Media (Thermo Scientific) following the manufacturer’s instructions. Then, the transfected cells were used in Th17 polarization as described above, followed by qRT-PCR and Western blot analysis.
+ Open protocol
+ Expand
7

Silencing MFG-E8 in HBVSMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HBVSMCs were seeded on poly-L-lysine-coated 48-well cell culture plates at a density of 15,000 cells/ml and were grown with DMEM complete serum medium for 48 h. A commercial Accell SMART pool of 4 short interfering RNAs (siRNAs, GE Dharmacon, Lafayette, CO, USA) was used to achieve MFG-E8 gene silencing. An Accell non-targeting siRNA pool (GE Dharmacon) was used as a negative control. The siRNAs were initially resuspended at 100 μM according to the manufacturer’s instructions. Cells were treated with 1 µM MFG-E8 siRNA or non-targeting siRNA. Forty-eight hours after transfection, fresh FBS-free medium was added, and the cells were then treated with 25 μM Aβ40-D for 2 days.
+ Open protocol
+ Expand
8

Alzheimer's Amyloid Beta Protein Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
GW3965 was synthesized as previously described (55 (link)). LPS from Salmonella minnesota R595 (Re) was obtained from Enzo Life Sciences. Thioflavin S was purchased from Sigma (T1892). Aβ(1 (link)–42 (link))-HiLyte488 and Aβ (1 (link)–42 (link))-HiLyte555 were purchased from AnaSpec. siRNAs for mouse Idol (SasI_Mm02_00343514) and mouse Ldlr (SasI_ Mm01_00084966) were purchased from Sigma (MISSION siRNA). Accell nontargeting siRNA pool and Accell mouse Ldlr (16835) siRNA SMARTpool were purchased from Dharmacon. The antibodies used were ABCA1 (Novus or HJ1, a gift from D. M. Holtzman), Aβ (4G8, Covance or 82E1, IBL International), actin (Abcam), ApoE (K23100R, Meridian Life Science), BACE1 (D10E5, Cell Signaling Technology), β-Gal (Promega), CD45 (MCA1388, Bio-Rad), glyceraldehyde-3-phosphate dehydrogenase (Santa Cruz Bio-technology), Iba1 (019–19741, Wako), LDLR (Cayman Chemical), LRP1 (Abcam), and mouse anti-tubulin (Abcam or EMB Millipore).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!